Hospital Corporation of China Ltd (HK:3869) has released an update.
Hospital Corporation of China Ltd reports a solid financial performance for the first half of 2024, with unaudited revenue reaching RMB 719.5 million, up slightly from the previous year’s RMB 717.8 million. The company has seen a significant increase in adjusted net profit to RMB 87.3 million from RMB 60.9 million in the corresponding period last year, alongside improvements in both gross profit and net profit margins. These positive results reflect the company’s growth in hospital management services and general hospital services, offsetting a decrease in pharmaceutical sales.
For further insights into HK:3869 stock, check out TipRanks’ Stock Analysis page.
